The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 5
- 3 new, 2 renewals
- Median first-year cost
- $1,659,230
- $8,140,977 in all
- Institutions
- 5
- 5 contact PIs
- Patents
- 2
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- DUKE UNIVERSITY1
- EMORY UNIVERSITY1
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
- UNIVERSITY OF FLORIDA1
Most frequent study sections
- Special Emphasis Panel (ZAG1 ZIJ-6 (A1))5
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2018 | Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease2U01AG046170-06 | Ehrlich, Michelle EGandy, Samuel E.Haroutunian, VahramNoggle, Scott AllenSchadt, Eric EZhang, Bin | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | First-year cost $1,708,836 | Study section ZAG1 |
| FY2018 | Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets1U01AG061356-01 | Bennett, David AlanDe Jager, Philip L | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $1,668,072 | Study section ZAG1 |
| FY2018 | Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD1U01AG061359-01 | Kaddurah-Daouk, Rima FKastenmuller, GabiVan Duijn, Cornelia Marja | DUKE UNIVERSITY, NC | First-year cost $1,659,230 | Study section ZAG1 |
| FY2018 | A Systems Approach to Targeting Innate Immunity in AD2U01AG046139-06 | Ertekin-Taner, NiluferGolde, Todd EPrice, Nathan D | UNIVERSITY OF FLORIDA, FL | First-year cost $1,613,148 | Study section ZAG1 |
| FY2018 | AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers1U01AG061357-01 | Levey, Allan ISeyfried, Nicholas ThomasShulman, Joshua M | EMORY UNIVERSITY, GA | First-year cost $1,491,691 | Study section ZAG1 |
Patents from its funded projects
2 patents name 1 of the 5 funded projects.
- US 11,149,250 (opens the patent at USPTO, a PDF, in a new tab)MICROGLIA DERIVED FROM PLURIPOTENT STEM CELLS AND METHODS OF MAKING AND USING THE SAMEGranted October 19, 2021 to New York Stem Cell Foundation, Inc.U01AG046170 · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY
- US 10,889,800 (opens the patent at USPTO, a PDF, in a new tab)METHOD AND COMPOSITION FOR GENERATING BASAL FOREBRAIN CHOLINERGIC NEURONS (BFCNS)Granted January 12, 2021 to New York Stem Cell Foundation, Inc. and Icahn School of Medicine at Mount SinaiU01AG046170 · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.